Article

Effect of volume on total hip arthroplasty revision rates in the United States Medicare population.

Homer Stryker Center for Orthopaedic Education, 325 Corporate Drive, Mahwah, NJ 07430, USA.
The Journal of Bone and Joint Surgery (Impact Factor: 4.31). 12/2008; 90(11):2446-51.
Source: PubMed

ABSTRACT Fewer short-term complications following total hip arthroplasty have been associated with greater hospital and surgeon procedure volume. It remains unclear if procedure volume is associated with longer-term clinical outcomes and revision rates. We examined the association between hospital and surgeon procedure volume and total hip arthroplasty revision rates in the Medicare population at six months to eight years postoperatively.
A subset of the 1997 to 2004 Medicare claims data was used to identify primary and revision total hip arthroplasties. The Kaplan-Meier method and Cox regression analysis were used to determine revision rates and hazard ratios associated with hospital and surgeon procedure volumes at 0.5, two, five, and eight years postoperatively.
About one-third of the primary hip procedures were done at hospitals with the highest annual volumes of total hip arthroplasties (more than 100). Surgeons with an annual volume of more than fifty procedures performed approximately one-sixth of the primary total hip arthroplasties. Patients who had been operated on by these surgeons had a lower revision rate at six months than did patients treated by surgeons with an annual volume of six to ten or eleven to twenty-five procedures (adjusted hazards ratio, 1.67 and 1.63, respectively). There was no effect of surgeon volume at the time of longer-term follow-up.
The majority of the total hip arthroplasties in the Medicare population from 1997 to 2004 were not performed by the highest-volume hospitals or surgeons. Our findings suggest that patients of low-volume surgeons have a greater risk of arthroplasty revision at six months but no greater risk of revision at the time of longer-term follow-up. There appeared to be no significant association between hospital volume and the rate of revisions of total hip arthroplasties.

0 Bookmarks
 · 
132 Views
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Total hip replacement causes a short-term increase in the risk of mortality. It is important to quantify this and to identify modifiable risk factors so that the risk of post-operative mortality can be minimised. We performed a systematic review and critical evaluation of the current literature on the topic. We identified 32 studies published over the last 10 years which provide either 30-day or 90-day mortality data. We estimate the pooled incidence of mortality during the first 30 and 90 days following hip replacement to be 0.30% (95% CI 0.22 to 0.38) and 0.65% (95% CI 0.50 to 0.81), respectively. We found strong evidence of a temporal trend towards reducing mortality rates despite increasingly co-morbid patients. The risk factors for early mortality most commonly identified are increasing age, male gender and co-morbid conditions, particularly cardiovascular disease. Cardiovascular complications appear to have overtaken fatal pulmonary emboli as the leading cause of death after hip replacement. Cite this article: Bone Joint Res 2014;3:175-82.
    Bone & joint research. 06/2014; 3(6):175-82.
  • [Show abstract] [Hide abstract]
    ABSTRACT: The substantial increase in the utilization of shoulder arthroplasty in the United States during the past decade is partly attributable to the growing acceptance of reverse shoulder arthroplasty (RSA). This study compared the national utilization of and indications for shoulder hemiarthroplasty, total shoulder arthroplasty (TSA), and RSA.
    Journal of Shoulder and Elbow Surgery 10/2014; · 2.37 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Regionalization of total joint arthroplasty (TJA) to high volume hospitals (HVH) may affect access to care and complication risk. Using administrative data, 2,560,314 patients who underwent primary total hip or knee arthroplasty from 1991-2006 were categorized by whether a HVH (> 200 annual TJA) was available locally. Associations among patient characteristics, hospital utilization, and in-hospital complications were estimated using regression modeling. The complication risk was higher (Odds Ratio 1.18 [95% CI: 1.16,1.20]) if patients went to a local low volume hospital rather than a local HVH. Black and Medicaid patients were more likely to utilize the local low volume hospital than a local HVH. Utilizing a local HVH is associated with lower complication risks. However, patients from vulnerable groups were less likely to utilize these patterns. Level of Evidence: Therapeutic, Level III.
    The Journal of Arthroplasty 09/2014; · 2.37 Impact Factor

Full-text (2 Sources)

Download
101 Downloads
Available from
May 20, 2014